Delta 9 Cannabis Inc (CVE:NINE) Director Sells C$40,560.00 in Stock

Delta 9 Cannabis Inc (CVE:NINEGet Rating) Director John William (John) Arbuthnot Iv sold 156,000 shares of the company’s stock in a transaction dated Friday, May 6th. The stock was sold at an average price of C$0.26, for a total transaction of C$40,560.00. Following the transaction, the director now owns 16,758,450 shares of the company’s stock, valued at approximately C$4,357,197.

John William (John) Arbuthnot Iv also recently made the following trade(s):

  • On Tuesday, May 31st, John William (John) Arbuthnot Iv bought 70,000 shares of Delta 9 Cannabis stock. The stock was bought at an average price of C$0.25 per share, with a total value of C$17,500.00.
  • On Wednesday, May 25th, John William (John) Arbuthnot Iv sold 325,000 shares of Delta 9 Cannabis stock. The stock was sold at an average price of C$0.24, for a total transaction of C$76,375.00.
  • On Friday, May 20th, John William (John) Arbuthnot Iv acquired 45,000 shares of Delta 9 Cannabis stock. The stock was bought at an average price of C$0.25 per share, with a total value of C$11,250.00.
  • On Wednesday, May 18th, John William (John) Arbuthnot Iv bought 34,000 shares of Delta 9 Cannabis stock. The shares were purchased at an average cost of C$0.25 per share, for a total transaction of C$8,500.00.
  • On Monday, May 9th, John William (John) Arbuthnot Iv sold 75,000 shares of Delta 9 Cannabis stock. The stock was sold at an average price of C$0.24, for a total value of C$17,625.00.
  • On Tuesday, May 3rd, John William (John) Arbuthnot Iv sold 128,000 shares of Delta 9 Cannabis stock. The stock was sold at an average price of C$0.27, for a total value of C$34,560.00.
  • On Friday, April 29th, John William (John) Arbuthnot Iv sold 145,000 shares of Delta 9 Cannabis stock. The stock was sold at an average price of C$0.28, for a total value of C$40,600.00.
  • On Thursday, March 31st, John William (John) Arbuthnot Iv bought 144,750 shares of Delta 9 Cannabis stock. The shares were purchased at an average cost of C$0.28 per share, for a total transaction of C$40,530.00.

CVE:NINE traded up C$0.03 during midday trading on Thursday, hitting C$1.03. 68,728 shares of the stock were exchanged, compared to its average volume of 117,300. Delta 9 Cannabis Inc has a one year low of C$0.92 and a one year high of C$2.35. The company has a market capitalization of C$89.36 million and a price-to-earnings ratio of 19.07. The business has a 50-day moving average price of C$1.03 and a two-hundred day moving average price of C$1.03. The company has a current ratio of 4.44, a quick ratio of 2.04 and a debt-to-equity ratio of 33.00.

Delta 9 Cannabis Company Profile (Get Rating)

Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers.

Featured Stories

Insider Buying and Selling by Quarter for Delta 9 Cannabis (CVE:NINE)

Receive News & Ratings for Delta 9 Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delta 9 Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.